MedPath

TVT-O versus TVT-S Trial.

Completed
Conditions
1. Urinary incontinence (NLD: urine incontinentie)
<br /> 2. stress incontinence
<br />3. prosthesis
<br />4. implants
<br />5. TVT
<br />6. TVT-o
<br />7. TOT
<br />8. TVT-s.
Registration Number
NL-OMON23119
Lead Sponsor
Jan-Paul W.R. Roovers, MD, PhD , Academisch Medisch Centrum, Amsterdam, the NetherlandsPiet Hinoul, MD, Ziekenhuis Oost Limburg, Genk, Belgium
Brief Summary

/A

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
200
Inclusion Criteria

Urodynamically proven urinary stress incontinence.

Exclusion Criteria

1. Stage 2 or more genital prolapse (ICS classification);

2. Recurrent stress-incontinence;

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Morbidity:<br /> <br>1. A questionnaire to assess activities of daily life;<br /><br>2. A visual analogue scale (VAS score) to assess the experienced pain.<br>
Secondary Outcome Measures
NameTimeMethod
1. General specific quality of life: SF-36;<br /><br>2. Disease specific quality of life: Urogenital;<br /> <br>3. Distress Inventory (UDI);<br /><br>4. Anatomical result – POP-Q score;<br /><br>5. Bladder function: voiding diary and uroflowmetry;<br /><br>6. Urogenital interventions in the first year after stress incontinence surgery;<br /><br>7. Catheter use.<br>
© Copyright 2025. All Rights Reserved by MedPath